These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29685674)

  • 1. Medication Cost Savings in Inpatient Oncology Using an Integrative Medicine Model.
    Estores IM; Arce L; Hix A; Mramba L; Warring CD; Leverence R
    Explore (NY); 2018; 14(3):212-215. PubMed ID: 29685674
    [No Abstract]   [Full Text] [Related]  

  • 2. Could integrative cancer treatment be cost-saving and resuscitate a submerged medical system?
    Block KI
    Integr Cancer Ther; 2009 Sep; 8(3):205-7. PubMed ID: 19815590
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost savings in inpatient oncology through an integrative medicine approach.
    Kligler B; Homel P; Harrison LB; Levenson HD; Kenney JB; Merrell W
    Am J Manag Care; 2011 Dec; 17(12):779-84. PubMed ID: 22216749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health economic studies on complementary and integrative medicine.
    Witt CM
    Forsch Komplementmed; 2011; 18(1):6-9. PubMed ID: 21372581
    [No Abstract]   [Full Text] [Related]  

  • 5. Health and medical economics applied to integrative medicine.
    Pelletier KR; Herman PM; Metz RD; Nelson CF
    Explore (NY); 2010; 6(2):86-99. PubMed ID: 20362266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost Savings from Reducing Pain Through the Delivery of Integrative Medicine Program to Hospitalized Patients.
    Dusek JA; Griffin KH; Finch MD; Rivard RL; Watson D
    J Altern Complement Med; 2018 Jun; 24(6):557-563. PubMed ID: 29474095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complementary medicine use and costs in patients with breast cancer who experienced treatment-related side effects: A cross-sectional survey in Korea.
    Han S; Jang BH; Suh HS; Hwang DS
    Complement Ther Med; 2019 Jun; 44():210-217. PubMed ID: 31126558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost savings with clinical solutions: the impact of reforming health and health care economics with integrative therapies.
    Block KI
    Integr Cancer Ther; 2010 Jun; 9(2):129-35. PubMed ID: 20603903
    [No Abstract]   [Full Text] [Related]  

  • 9. Economic analysis of complementary, alternative, and integrative medicine: considerations raised by an expert panel.
    Coulter ID; Herman PM; Nataraj S; ; ; ;
    BMC Complement Altern Med; 2013 Jul; 13():191. PubMed ID: 23885789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Problematic Economics of Integrative Oncology.
    Herman PM
    J Altern Complement Med; 2018; 24(9-10):1025-1027. PubMed ID: 30247954
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and cost outcomes of an integrative medicine IPA.
    Sarnat RL; Winterstein J
    J Manipulative Physiol Ther; 2004 Jun; 27(5):336-47. PubMed ID: 15195041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative cost analysis of inpatient integrative medicine-Results of a pilot study.
    Ostermann T; Lauche R; Cramer H; Dobos G
    Complement Ther Med; 2017 Jun; 32():129-133. PubMed ID: 28619299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current resources for evidence-based practice March/April 2013.
    Avery MD
    J Obstet Gynecol Neonatal Nurs; 2013; 42(2):E44-51. PubMed ID: 23373557
    [No Abstract]   [Full Text] [Related]  

  • 14. National Cancer Institute's support of research to further integrative oncology practice.
    White JD
    J Natl Cancer Inst Monogr; 2014 Nov; 2014(50):286-7. PubMed ID: 25749590
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost analysis in a Traditional, Complementary and Integrative Medicine unit in Brazil.
    Assunção MCT; Aquino CMF; Sousa IMC; Carvalho Neto MR; Jordão VP; Bezerra AFB
    Rev Saude Publica; 2020; 54():145. PubMed ID: 33331423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative medicine in hematology/oncology: benefits, ethical considerations, and controversies.
    Rosenthal DS; Dean-Clower E
    Hematology Am Soc Hematol Educ Program; 2005; ():491-7. PubMed ID: 16304425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New JACM Column Partnership with the Osher Collaborative for Integrative Medicine.
    Weeks J
    J Altern Complement Med; 2018 Feb; 24(2):99-100. PubMed ID: 29406786
    [No Abstract]   [Full Text] [Related]  

  • 18. "Come Home": A Medicare Innovation Center project.
    McAneny BL
    Oncology (Williston Park); 2012 Dec; 26(12):1145, 1156. PubMed ID: 23413590
    [No Abstract]   [Full Text] [Related]  

  • 19. [Complementary medicine in oncology].
    Rostock M; Saller R
    Forsch Komplementmed; 2011; 18(4):174-5. PubMed ID: 21934316
    [No Abstract]   [Full Text] [Related]  

  • 20. Quality management in complementary and integrative medicine.
    Witt CM; Berghoefer A
    Forsch Komplementmed; 2009 Jun; 16(3):190-4. PubMed ID: 19657204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.